Safety and Efficacy of Endoscopic Ultrasound (EUS) Guided Radiofrequency Ablation (RFA) in the Treatment of Pancreatic Lesions

Recruiting now

Conditions studied: Pancreatic Cancer

In brief

This is a 7-year prospective single-center registry study to assess the safety and efficacy of Endoscopic Ultrasound (EUS) Guided Radiofrequency Ablation (RFA) in the treatment of pancreatic lesions.

Key facts

Study ID

NCT07737171

Run by

The University of Texas Health Science Center, Houston

People needed

60

Starts

2026-04-07

Expected to finish

2033-04-01

Last updated by the study team

2026-07-30

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of any pancreatic pre-malignant lesion and/or pancreatic malignancy
• Patients already undergoing EUS-RFA for treatment of pancreatic lesions clinically

You may not qualify if…

• Patients with co-existing malignancies of other organs (or a prior history of such)
• Patients unable to provide informed consent
• Patients unable to complete follow-up

Where it is running

• The University of Texas Health Science Center at Houston — Houston, Texas, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.